We've built AI Governance Boards in highly regulated biopharma environments. Not theoretical frameworks, actual working governance systems with review processes, bias detection protocols, data protection controls, and model evaluation criteria that let teams ship AI where regulators hold you to an extremely high bar.
Here's what I learned: governance doesn't have to slow you down. Done right, it actually speeds you up, because people trust the AI systems and the organization trusts the team deploying them.
The Three Pillars
Risk Classification. Not every AI use case carries the same risk. An internal search tool is different from a customer-facing recommendation engine. Classify your use cases by risk level, and apply proportional review. Low-risk use cases get fast-tracked. High-risk ones get thorough review. This avoids the common failure mode of applying the same heavyweight process to everything.
Technical Controls. Governance isn't just policy documents. It's audit logging, prompt safety checks, data access controls, model evaluation pipelines, and bias detection tools built into the platform. If your governance relies entirely on human review, it won't scale.
Organizational Accountability. Someone needs to own AI governance, not as a side project, but as a primary responsibility. We've seen this work best with a formal AI Governance Board with cross-functional representation. Clear ownership made everything else possible.
Start Here
If you're just getting started with AI governance: classify your use cases by risk, put technical controls in your platform architecture from day one, and designate a clear owner. You don't need a 50-page policy document to get started. You need a decision-making framework and the technical infrastructure to enforce it.